Laura K. Aguilar - 06 May 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Reporting relationship: 10%+ Owner
Issuer ticker: CADL
Reported as of: 06 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 May 2022, 18:07:21 UTC
Prior SEC filing: 02 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ John Canepa, Attorney-in-Fact

Key filing fact

Laura K. Aguilar filed Form 4 for Candel Therapeutics, Inc. (CADL) on 10 May 2022.

Key facts

This page summarizes Laura K. Aguilar's Form 4 filing for Candel Therapeutics, Inc. (CADL).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 10 May 2022, 18:07.

Change

Previous filing in this sequence was filed on 02 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CADL transaction

Common Stock

Options Exercise

Transaction value: $250,149
Shares: +171,335
Change %: +18%
Price: $1.46
Shares after: 1,102,374
Date: 06 May 2022
Ownership: Direct
Footnotes: F1

CADL transaction

Common Stock

Tax liability

Transaction value: $250,149
Shares: -68,534
Change %: -6.2%
Price: $3.65
Shares after: 1,033,840
Date: 06 May 2022
Ownership: Direct
Footnotes: F1, F2

CADL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,013,100
Date: 06 May 2022
Ownership: By Laura K. Aguilar 2020 Irrevocable Trust
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CADL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -17,901
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,901
Exercise price: $1.46
Footnotes: F4

CADL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -76,717
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 76,717
Exercise price: $1.46
Footnotes: F4

CADL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -76,717
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 76,717
Exercise price: $1.46
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Includes 32,399 shares of common stock held jointly with spouse.

Footnote F2

Represents a net exercise of outstanding stock options. These shares were resold to the Issuer as payment of the exercise price, based on the closing price of the Issuer's common stock on May 5, 2022 of $3.65 per share.

Footnote F3

Shares held by the Laura K. Aguilar 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.

Footnote F4

This option is fully vested and exercisable as of the date hereof.

Footnote F5

Includes options that were previously subject to performance vesting criteria. Upon the Reporting Person's termination as an officer of the Issuer, the vesting conditions were waived, and the shares underlying this option became fully vested and exercisable.